Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC: Disclosure-Free Claims Could Solve Digital Dilemmas

This article was originally published in The Tan Sheet

Executive Summary

Limited screen space on mobile devices and apps does not absolve firms from complying with FTC guidance on claims and disclosures. FTC officials discussed “dot-com” disclosures at the Council of Better Business Bureaus’ Advertising Self-Regulatory Council conference and offered advice on compliance.

You may also be interested in...



FTC Updates Policy For Unmasking 'Native Advertising'

FTC publishes an enforcement policy statement addressing a rise in native advertising and deceptively formatted ads. The statement explains how the commission will apply its current enforcement standards to target deceptive content, including promotions disguised as news stories in violation of its policies.

FTC Targets Unmasking 'Native Advertising' In Policy Update

FTC publishes enforcement policy statement addressing increases in native advertising and deceptively formatted ads. The statement explains how the commission will apply its current enforcement standards to target deceptive content, including promotions disguised as news stories, in violation of its policies.

FTC Brings Dot-Com Disclosure Guide To Social Media, Mobile Era

Revised online advertising disclosure guidelines detail FTC’s expectations for how advertisers should craft disclosures in the world of social media and mobile devices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106667

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel